当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
VEKLURY (remdesivir)
药品名称
VEKLURY (remdesivir)
承诺描述
Submit all sequencing data from ACTT-1, GS-540-5773, and GS-US-540-5774 assessing remdesivir including sequencing of any subject samples that have not been completed to date